Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer [Phase 2]
Phase 2 trial update on tislelizumab plus anlotinib for immunotherapy-resistant gastric and colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer [Phase 1, Phase 2]
Phase 1/2 trial investigating Nab-PTX plus S-1 and Sintilimab as adjuvant therapy for Stage IIIC gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy [Phase 2]
Phase 2 trial updating on receiving modified chemotherapy followed by radical resection after neoadjuvant chemotherapy for locally advanced …
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus [Phase 3]
Phase 3 trial update evaluating surgery with or without combination chemotherapy in esophageal and gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer [Phase 2]
Phase 2 trial update evaluating toripalimab in combination with FLOT neoadjuvant chemotherapy for resectable gastric cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Chemotherapy for Patients With Cancer of the Stomach [Phase 1]
Phase 1 trial update for chemotherapy in first-line treatment of non-resectable gastric cancer or cancer of the esophagus; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies [Phase 1, Phase 2]
Clinical trial update on autologous CAR-T/TCR-T cell therapy for solid malignancies across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating raltitrexed with paclitaxel for gastric cancer and gastroesophageal junction adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer [Phase 2]
Phase 2 trial evaluating a combination of docetaxel, oxaliplatin, capecitabine, bevacizumab, and trastuzumab in locally advanced or metastat…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer [Phase 3]
Phase 3 trial evaluating oxaliplatin with S-1 (SOX) as neoadjuvant chemotherapy for gastric cancer; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial assessing efficacy and safety of S-1 plus oxaliplatin as first-line treatment in elderly patients with advanced gastr…
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: EGFR Monoclonal Antibody for Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update evaluating an EGFR-targeting monoclonal antibody for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients [Phase 2, Phase 3]
A clinical trial comparing neoadjuvant chemotherapy plus surgery versus surgery first in elderly gastric cancer patients, currently not yet …
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer [Phase 2]
Phase II trial assessing AUY922 versus comparators in advanced gastric cancer and gastro-esophageal junction cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer [Phase 2]
A phase 2 clinical trial evaluating mesylate apatinib combined with docetaxel and S-1 as first-line therapy for metastatic gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients [Phase 2]
Phase 2 trial evaluating a sequencing regimen of oxaliplatin/irinotecan/bevacizumab followed by docetaxel/bevacizumab in unresectable locall…
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] [Phase 2]
Phase 2 trial Destiny-Gastric01 evaluating DS-8201a (trastuuzumab deruxtecan) in HER2-expressing gastric cancer has completed with posted re…
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 2]
Phase 2 trial evaluating conversion therapy with Camrelizumab plus chemoradiotherapy in patients with initially unresectable gastric or GEJ …
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer [Phase 2]
Phase 2 clinical trial update evaluating the efficacy and safety of apatinib combined with S-1 for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific Markers [Phase 2]
Phase 2 clinical trial evaluating toripalimab for recurrent or metastatic gastric or gastroesophageal junction adenocarcinoma after failure …
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer [Phase 3]
Phase 3 clinical trial updating first-line chemotherapy options for elderly patients with advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy and radiation therapy in patients with gastric cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers [EARLY_Phase 1]
Early-phase trial evaluating postoperative chemoradiation or chemotherapy after preoperative chemotherapy for gastric cancers; study termina…
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer [Phase 1, Phase 2]
Clinical trial evaluating camrelizumab plus apatinib and nab-paclitaxel for second-line advanced gastric cancer (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment [Phase 1, Phase 2]
A clinical trial update for MG-7-DC vaccine in gastric cancer spanning Phase 1 and Phase 2 to assess safety and efficacy.